Avalo Therapeutics Inc.
AVTX | NASDAQ
$16.60
+$0.43 (+2.66%)
Sep 22, 2026, 11:40 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | 59K | n/a | n/a | n/a | 192K | 249K | n/a | n/a | 571K | 236K | 643K | 475K | 896K | 14.95M | 1.03M | 1.17M | 219K | 1.35M | 3.36M | 473K |
Cost of Revenue | n/a | 17K | n/a | 9.99M | 10.66M | 5.91M | 87K | -714K | 343K | -80K | -221K | 240K | 708K | 4.98M | 620K | 528K | 1.57M | 720K | 8.76M | 908K | 9.96M | 77K |
Gross Profit | n/a | -17K | 59K | -9.99M | -10.66M | -5.91M | 105K | 963K | -343K | 80K | 792K | -4K | -65K | -4.51M | 276K | 14.42M | -534K | 453K | -8.54M | 442K | -6.6M | 396K |
Operating Income | -31.52M | -20.9M | -19.74M | -19.2M | -19.32M | -14.67M | -13.31M | -12.86M | -9.58M | -32.77M | -3.75M | -3.75M | -7.15M | -8.79M | -8.86M | 4.1M | -11.83M | -20.85M | -17.96M | -16.46M | -26.58M | -30.58M |
Interest Income | 2.76M | 803K | 992K | 1.12M | 1.1M | 1.15M | 1.22M | 964K | 1.04M | 100K | 81K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 17K |
Pretax Income | -36.34M | -19.62M | -13.59M | -30.61M | -20.75M | -13.14M | -35.23M | 23.02M | 98.47M | -121.28M | -8.18M | -5.22M | -8.19M | -9.95M | -9.8M | 3.2M | -12.98M | -22.04M | -19.12M | -17.46M | -16.98M | -30.56M |
Net Income | -36.36M | -19.63M | -13.72M | -30.63M | -20.77M | -13.15M | -35.34M | 23.04M | 98.46M | -121.29M | -8.17M | -5.23M | -8.19M | -9.96M | -9.81M | 3.19M | -12.99M | -22.05M | -19.2M | -17.4M | -17.11M | -30.68M |
Selling & General & Admin | 8.1M | 6.84M | 6.53M | 5.58M | 5.24M | 5.55M | 5.23M | 4.29M | 4.53M | 3.19M | 2.68M | 2.49M | 2.43M | 2.71M | 2.96M | 3.28M | 2.78M | 11.68M | 5.98M | 5.93M | 7.4M | 5.35M |
Research & Development | 23.42M | 14.05M | 13.27M | 13.62M | 14.07M | 9.12M | 8.18M | 9.54M | 4.7M | 29.65M | 1.87M | 1.25M | 4.66M | 6.01M | 6.17M | 7.04M | 8.51M | 9.58M | 11.51M | 10.55M | 12.57M | 25.21M |
Other Expenses | n/a | n/a | n/a | -9.99M | -10.66M | -5.91M | n/a | n/a | n/a | n/a | n/a | 7K | n/a | -4.43M | n/a | n/a | n/a | 38K | -8.07M | 428K | n/a | 424K |
Operating Expenses | 31.52M | 20.88M | 19.8M | 9.21M | 8.66M | 8.76M | 13.42M | 13.82M | 9.23M | 32.85M | 4.54M | 3.75M | 7.09M | 4.28M | 9.13M | 10.33M | 11.29M | 21.31M | 9.42M | 16.91M | 19.97M | 30.98M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.55M | 996K | 949K | 949K | 898K | 1.15M | 1.17M | 1.18M | 985K | 239K | n/a |
Selling & Marketing Expenses | n/a | n/a | 381K | 22K | 56K | 12K | 789K | 142K | 21K | 7K | 7K | n/a | 7K | 13K | 12K | 6K | 14K | 1.93M | 1.66M | 482K | 432K | 435K |
Cost & Expenses | 31.52M | 20.9M | 19.8M | 19.2M | 19.32M | 14.67M | 13.5M | 13.11M | 9.58M | 32.77M | 4.32M | 3.99M | 7.79M | 9.27M | 9.75M | 10.85M | 12.86M | 22.03M | 18.18M | 17.81M | 29.93M | 31.05M |
Income Tax Expense | 18K | 12K | 130K | 11K | 16K | 8K | 114K | -14K | 7K | 7K | -9K | 8K | 7K | 8K | 8K | 5K | 5K | 9K | 16K | 8K | 199K | 11K |
Shares Outstanding (Basic) | 43.6M | 20.11M | 18.51M | 14M | 10.83M | 10.51M | 10.47M | 5.55M | 1.03M | 859.38K | 801.75K | 194.85K | 58.22K | 48.85K | 39.25K | 39.22K | 39.17K | 39.17K | 39.63K | 34.89K | 37.71K | 32.94K |
Shares Outstanding (Diluted) | 43.6M | 20.11M | 18.51M | 14M | 10.83M | 10.51M | 10.47M | 10.78M | 7.65M | 859.38K | 801.75K | 194.85K | 58.22K | 48.85K | 39.25K | 39.22K | 39.17K | 39.17K | 39.63K | 34.89K | 37.71K | 32.94K |
EPS (Basic) | -0.83 | -0.98 | -0.74 | -2.19 | -1.92 | -1.25 | 13.89 | 2.83 | 95.21 | -141.14 | -10.19 | -26.83 | -140.73 | -203.81 | -249.99 | 81.38 | -331.55 | -563.03 | -484.39 | -498.52 | -453.56 | -931.42 |
EPS (Diluted) | -0.83 | -0.98 | -0.74 | -2.19 | -1.92 | -1.25 | 10.47 | 2.14 | 12.87 | -141.14 | -10.19 | -26.83 | -140.73 | -203.81 | -249.99 | 81.38 | -331.55 | -563.03 | -484.39 | -498.52 | -453.56 | -931.42 |
EBITDA | -36.31M | -19.6M | -13.57M | -30.56M | -20.62M | -13.01M | -35.16M | 23.06M | 98.5M | -121.25M | -8.22M | -3.63M | -7.15M | -8.97M | -8.82M | 4.13M | -11.8M | -20.81M | -17.64M | -16.02M | -16.67M | -30.13M |
EBIT | -36.34M | -19.62M | -13.59M | -30.61M | -20.75M | -13.14M | -35.23M | 23.02M | 98.47M | -121.28M | -8.26M | -3.67M | -7.19M | -9M | -8.86M | 4.1M | -11.83M | -20.87M | -17.93M | -16.48M | -17.13M | -30.58M |
Depreciation & Amortization | 34K | 17K | 16K | 59K | 134K | 135K | 68K | 34K | 33K | 34K | 43K | 41K | 41K | 33K | 35K | 34K | 30K | 67K | 295K | 455K | 456K | 451K |
Add to Watchlist
Select watchlists to add or remove AVTX